Canoe Financial LP Bristol Myers Squibb CO Transaction History

Canoe Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $4.65 Million - $5.28 Million	97,000 New	97,000 $5.26 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $26.5 Million - $31.6 Million	-546,810 Reduced 84.93%	97,000 $113 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $26.7 Million - $29.9 Million	-461,438 Reduced 41.75%	643,810 $50.8 Billion
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $1.16 Million - $1.29 Million	18,198 Added 1.67%	1,105,248 $70.7 Billion
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $71.4 Million - $81 Million	1,087,050 New	1,087,050 $75.3 Billion

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Canoe Financial LP, based on Form 13F filings with the SEC.

Stay updated on Canoe Financial LP with notifications on news.